Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LNTH - Lantheus Holdings Inc


IEX Last Trade
106.49
1.680   1.578%

Share volume: 716,861
Last Updated: Fri 30 Aug 2024 09:59:49 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$104.81
1.68
1.60%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-0.64%
1 Month
-3.01%
3 Months
32.23%
6 Months
62.87%
1 Year
57.06%
2 Year
37.61%
Key data
Stock price
$106.49
P/E Ratio 
17.25
DAY RANGE
N/A - $108.32
EPS 
$6.06
52 WEEK RANGE
$50.20 - $126.89
52 WEEK CHANGE
$0.58
MARKET CAP 
7.392 B
YIELD 
N/A
SHARES OUTSTANDING 
69.431 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
0.86
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$814,402
AVERAGE 30 VOLUME 
$797,244
Company detail
CEO: Mary Heino
Region: US
Website: http://www.lantheus.com/
Employees: 792
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.

Recent news